<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">and </span>
   <span class="font30">the </span>
   <span class="font15">for </span>
   <span class="font15">PTSD </span>
   <span class="font14">with </span>
   <span class="font13">[]. </span>
   <span class="font12">studies </span>
   <span class="font12">treatment </span>
   <span class="font12">was </span>
   <span class="font12">that </span>
   <span class="font12">were </span>
   <span class="font12">{background </span>
   <span class="font12">The </span>
   <span class="font12">cannabis </span>
   <span class="font11">stress </span>
   <span class="font11">clinical </span>
   <span class="font11">margin </span>
   <span class="font11">CBD </span>
   <span class="font11">included </span>
   <span class="font11">{border-style </span>
   <span class="font11">px;} </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">Stress </span>
   <span class="font11">also </span>
   <span class="font11">[,]. </span>
   <span class="font11">effects </span>
   <span class="font11">from </span>
   <span class="font11">may </span>
   <span class="font11">medicinal </span>
   <span class="font11">could </span>
   <span class="font11">different </span>
   <span class="font11">dose </span>
   <span class="font11">sleep </span>
   <span class="font11">symptoms </span>
   <span class="font11">are </span>
   <span class="font11">cannabinoids </span>
   <span class="font11">THC </span>
   <span class="font11">cannabidiol </span>
   <span class="font11">subjects </span>
   <span class="font11">use </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">[], </span>
   <span class="font11">cannabinoid </span>
   <span class="font11">eCBS </span>
   <span class="font11">scores </span>
   <span class="font11">system </span>
   <span class="font11">two </span>
   <span class="font10">disorder </span>
   <span class="font10">mean </span>
   <span class="font10">not </span>
   <span class="font10">quality </span>
   <span class="font10">research </span>
   <span class="font10">which </span>
   <span class="font10">.), </span>
   <span class="font10">al. </span>
   <span class="font10">aversive </span>
   <span class="font10">evidence </span>
   <span class="font10">extinction </span>
   <span class="font10">receptor </span>
   <span class="font10">receptors </span>
   <span class="font10">reduction </span>
   <span class="font10">score </span>
   <span class="font10">social </span>
   <span class="font10">studyGrade: </span>
   <span class="font10">systematic </span>
   <span class="font10">(e.g., </span>
   <span class="font10">Cannabis </span>
   <span class="font10">Post-Traumatic </span>
   <span class="font10">This </span>
   <span class="font10">[,], </span>
   <span class="font10">after </span>
   <span class="font10">data </span>
   <span class="font10">further </span>
   <span class="font10">mg/d </span>
   <span class="font10">nabilone </span>
   <span class="font10">only </span>
   <span class="font10">present </span>
   <span class="font10">significant </span>
   <span class="font10">specific </span>
   <span class="font10">study </span>
   <span class="font10">synthetic </span>
   <span class="font10">traumatic </span>
   <span class="font10">(range </span>
   <span class="font10">CAPS </span>
   <span class="font10">Changes </span>
   <span class="font10">Clin. </span>
   <span class="font10">Clinical </span>
   <span class="font10">None </span>
   <span class="font10">about </span>
   <span class="font10">administration </span>
   <span class="font10">age </span>
   <span class="font10">anxiety </span>
   <span class="font10">been </span>
   <span class="font10">efficacy </span>
   <span class="font10">emotional </span>
   <span class="font10">endocannabinoid </span>
   <span class="font10">have </span>
   <span class="font10">improvement </span>
   <span class="font10">maximum </span>
   <span class="font10">most </span>
   <span class="font10">nightmares </span>
   <span class="font10">pain </span>
   <span class="font10">post-traumatic </span>
   <span class="font10">px; </span>
   <span class="font10">review </span>
   <span class="font10">such </span>
   <span class="font10">their </span>
   <span class="font10">well </span>
   <span class="font10">{font-family </span>
   <span class="font10">âˆ’ </span>
   <span class="font10">Disorder </span>
   <span class="font10">Mental </span>
   <span class="font10">Posttraumatic </span>
   <span class="font10">Treatment </span>
   <span class="font10">amygdala </span>
   <span class="font10">based </span>
   <span class="font10">can </span>
   <span class="font10">decrease </span>
   <span class="font10">diagnosis </span>
   <span class="font10">font-size </span>
   <span class="font10">has </span>
   <span class="font10">its </span>
   <span class="font10">medical </span>
   <span class="font10">memories </span>
   <span class="font10">one </span>
   <span class="font10">possible </span>
   <span class="font10">responses </span>
   <span class="font10">risk </span>
   <span class="font10">symptom </span>
   <span class="font10">this </span>
   <span class="font10">variable </span>
   <span class="font10">weeks </span>
   <span class="font10">â€" </span>
   <span class="font10">Biol. </span>
   <span class="font10">Manual </span>
   <span class="font10">Neuro-Psychopharmacol. </span>
   <span class="font10">PTSD, </span>
   <span class="font10">Quality </span>
   <span class="font10">Review </span>
   <span class="font10">Statistical </span>
   <span class="font10">activation </span>
   <span class="font10">arousal </span>
   <span class="font10">brain </span>
   <span class="font10">chronic </span>
   <span class="font10">considered </span>
   <span class="font10">double-blind, </span>
   <span class="font10">double; </span>
   <span class="font10">endogenous </span>
   <span class="font10">evaluated </span>
   <span class="font10">g/d </span>
   <span class="font10">literature </span>
   <span class="font10">mainly </span>
   <span class="font10">medications </span>
   <span class="font10">nightmares, </span>
   <span class="font10">oil </span>
   <span class="font10">randomized, </span>
   <span class="font10">reducing </span>
   <span class="font10">reported </span>
   <span class="font10">response </span>
   <span class="font10">several </span>
   <span class="font10">since </span>
   <span class="font10">target </span>
   <span class="font10">therapeutic </span>
   <span class="font10">Canada </span>
   <span class="font10">Diagnostic </span>
   <span class="font10">Disorder: </span>
   <span class="font10">Drug </span>
   <span class="font10">Global </span>
   <span class="font10">HPA </span>
   <span class="font10">Psychiatry./j.pnpbp... </span>
   <span class="font10">Risk </span>
   <span class="font10">Significant </span>
   <span class="font10">axis </span>
   <span class="font10">bias </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">conducted </span>
   <span class="font10">disorder: </span>
   <span class="font10">doses </span>
   <span class="font10">due </span>
   <span class="font10">effect </span>
   <span class="font10">following </span>
   <span class="font10">formulations </span>
   <span class="font10">functional </span>
   <span class="font10">group </span>
   <span class="font10">impact </span>
   <span class="font10">information </span>
   <span class="font10">interest </span>
   <span class="font10">modulation </span>
   <span class="font10">neurotransmitter </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">potential </span>
   <span class="font10">reduction, </span>
   <span class="font10">represent </span>
   <span class="font10">role </span>
   <span class="font10">safety </span>
   <span class="font10">search </span>
   <span class="font10">solid; </span>
   <span class="font10">time </span>
   <span class="font10">used </span>
   <span class="font10">whilst </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">Î"-tetrahydrocannabinol </span>
   <span class="font10">(PTSD): </span>
   <span class="font10">(THC </span>
   <span class="font10">*** </span>
   <span class="font10">/âˆ’ </span>
   <span class="font10">CBD, </span>
   <span class="font10">Disorders, </span>
   <span class="font10">Endocannabinoid </span>
   <span class="font10">Evidence </span>
   <span class="font10">Indeed, </span>
   <span class="font10">Medical </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Nightmare </span>
   <span class="font10">PTSD-related </span>
   <span class="font10">PTSD. </span>
   <span class="font10">PTSD: </span>
   <span class="font10">Psychiatric </span>
   <span class="font10">Psychiatry </span>
   <span class="font10">Results </span>
   <span class="font10">Retrospective </span>
   <span class="font10">Studies </span>
   <span class="font10">Study </span>
   <span class="font10">Systematic </span>
   <span class="font10">Table </span>
   <span class="font10">[,,]. </span>
   <span class="font10">action </span>
   <span class="font10">acute </span>
   <span class="font10">affected </span>
   <span class="font10">agonist </span>
   <span class="font10">alternative </span>
   <span class="font10">among </span>
   <span class="font10">article </span>
   <span class="font10">bold </span>
   <span class="font10">both </span>
   <span class="font10">but </span>
   <span class="font10">changes </span>
   <span class="font10">cognitive </span>
   <span class="font10">comorbidity </span>
   <span class="font10">courier; </span>
   <span class="font10">demonstrated </span>
   <span class="font10">duration </span>
   <span class="font10">effectiveness </span>
   <span class="font10">eligible </span>
   <span class="font10">em; </span>
   <span class="font10">event, </span>
   <span class="font10">explain </span>
   <span class="font10">expression </span>
   <span class="font10">fear </span>
   <span class="font10">focused </span>
   <span class="font10">frequency </span>
   <span class="font10">future </span>
   <span class="font10">high </span>
   <span class="font10">life </span>
   <span class="font10">mechanism </span>
   <span class="font10">mg) </span>
   <span class="font10">modulate </span>
   <span class="font10">more </span>
   <span class="font10">negative </span>
   <span class="font10">new </span>
   <span class="font10">observational </span>
   <span class="font10">overall </span>
   <span class="font10">pathophysiology </span>
   <span class="font10">patients </span>
   <span class="font10">performed </span>
   <span class="font10">plays </span>
   <span class="font10">posttraumatic </span>
   <span class="font10">preclinical </span>
   <span class="font10">preliminary </span>
   <span class="font10">promising </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">rating </span>
   <span class="font10">related </span>
   <span class="font10">reporting </span>
   <span class="font10">results </span>
   <span class="font10">should </span>
   <span class="font10">showed </span>
   <span class="font10">signaling </span>
   <span class="font10">some </span>
   <span class="font10">suggested </span>
   <span class="font10">suicidal </span>
   <span class="font10">symptomatology </span>
   <span class="font10">than </span>
   <span class="font10">there </span>
   <span class="font10">thus </span>
   <span class="font10">treat </span>
   <span class="font10">treatments </span>
   <span class="font10">veterans </span>
   <span class="font10">without </span>
   <span class="font10">â€") </span>
  </p>
 </body>
</html>
